Pages that link to "Item:Q908029"
From MaRDI portal
The following pages link to A Bayesian dose-finding design for drug combination trials with delayed toxicities (Q908029):
Displaying 11 items.
- Bootstrap aggregating continual reassessment method for dose finding in drug-combination trials (Q512445) (← links)
- Adaptive designs for drug combination informed by longitudinal model for the response (Q2423165) (← links)
- Bayesian dose finding for combined drugs with discrete and continuous doses (Q2633955) (← links)
- Constructing Release Targets for Drug Products: A Bayesian Decision Theory Approach (Q4843959) (← links)
- Application of gamma process to two-agent combinations with delayed toxicity (Q5083969) (← links)
- A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome (Q5208130) (← links)
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers (Q5450494) (← links)
- A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (Q5866135) (← links)
- Flexible use of copula‐type model for dose‐finding in drug combination clinical trials (Q6055718) (← links)
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905) (← links)
- Statistical frameworks for oncology dose-finding designs with late-onset toxicities: a review (Q6577811) (← links)
